265 related articles for article (PubMed ID: 15520606)
1. Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics.
Klein N; Sacher J; Wallner H; Tauscher J; Kasper S
CNS Spectr; 2004 Nov; 9(11):823-32. PubMed ID: 15520606
[TBL] [Abstract][Full Text] [Related]
2. Treatment-resistant depression: new therapies on the horizon.
Trivedi MH
Ann Clin Psychiatry; 2003 Mar; 15(1):59-70. PubMed ID: 12839433
[TBL] [Abstract][Full Text] [Related]
3. Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials.
Wang HR; Woo YS; Ahn HS; Ahn IM; Kim HJ; Bahk WM
Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25770098
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
Thomas SJ; Shin M; McInnis MG; Bostwick JR
Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options in treatment-resistant depression.
Vieta E; Colom F
Ann Med; 2011 Nov; 43(7):512-30. PubMed ID: 21623700
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for treatment-resistant depression.
Shelton RC; Osuntokun O; Heinloth AN; Corya SA
CNS Drugs; 2010 Feb; 24(2):131-61. PubMed ID: 20088620
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder.
Papakostas GI
Essent Psychopharmacol; 2005; 6(4):209-20. PubMed ID: 16041917
[TBL] [Abstract][Full Text] [Related]
8. Treatment-resistant depression.
Souery D; Papakostas GI; Trivedi MH
J Clin Psychiatry; 2006; 67 Suppl 6():16-22. PubMed ID: 16848672
[TBL] [Abstract][Full Text] [Related]
9. Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview.
Berlim MT; Fleck MP; Turecki G
Ann Med; 2008; 40(2):149-59. PubMed ID: 18293145
[TBL] [Abstract][Full Text] [Related]
10. Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics.
Kennedy SH; Lam RW
Bipolar Disord; 2003; 5 Suppl 2():36-47. PubMed ID: 14700011
[TBL] [Abstract][Full Text] [Related]
11. The hidden third: improving outcome in treatment-resistant depression.
Schlaepfer TE; Agren H; Monteleone P; Gasto C; Pitchot W; Rouillon F; Nutt DJ; Kasper S
J Psychopharmacol; 2012 May; 26(5):587-602. PubMed ID: 22236505
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics.
Vas C; Jain A; Trivedi M; Jha MK; Mathew SJ
Psychiatr Clin North Am; 2023 Jun; 46(2):261-275. PubMed ID: 37149344
[TBL] [Abstract][Full Text] [Related]
13. Medication options in the treatment of treatment-resistant depression.
Pridmore S; Turnier-Shea Y
Aust N Z J Psychiatry; 2004 Apr; 38(4):219-25. PubMed ID: 15038800
[TBL] [Abstract][Full Text] [Related]
14. Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics.
Cepeda MS; Reps J; Fife D; Blacketer C; Stang P; Ryan P
Depress Anxiety; 2018 Mar; 35(3):220-228. PubMed ID: 29244906
[TBL] [Abstract][Full Text] [Related]
15. Depression: Managing Resistance and Partial Response to Treatment.
Gaddey HL; Mason B; Naik A
Am Fam Physician; 2024 May; 109(5):410-416. PubMed ID: 38804755
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and definition of treatment-resistant depression.
Fava M
Biol Psychiatry; 2003 Apr; 53(8):649-59. PubMed ID: 12706951
[TBL] [Abstract][Full Text] [Related]
17. Annual Research Review: Defining and treating pediatric treatment-resistant depression.
Dwyer JB; Stringaris A; Brent DA; Bloch MH
J Child Psychol Psychiatry; 2020 Mar; 61(3):312-332. PubMed ID: 32020643
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
Jha MK; Mathew SJ
Am J Psychiatry; 2023 Mar; 180(3):190-199. PubMed ID: 36855876
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Shelton RC; Papakostas GI
Acta Psychiatr Scand; 2008 Apr; 117(4):253-9. PubMed ID: 18190674
[TBL] [Abstract][Full Text] [Related]
20. Optimized Treatment Strategy for Depressive Disorder.
Chen P
Adv Exp Med Biol; 2019; 1180():201-217. PubMed ID: 31784965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
